HNPCC
11
2
2
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 8 completed trials
Clinical Trials (11)
Liquid Biopsy Biomarkers for Endoscopic Surveillance in Lynch Syndrome
Pancreatic Cancer Early Detection Program
Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM)
A Prospective, Single-arm, Phase II Clinical Trial of Becotatug Vedotin for Injection Combined With Pucotenlimab Injection as a First-line Treatment for Platinum-intolerant Advanced Head and Neck Squamous Cell Carcinoma
Lynch Syndrome X-Talk of Enteral Mucosa With Immune System
Molecular Screening for Lynch Syndrome in Denmark
Uncertain Genetic Test Results for Lynch Syndrome
Preliminary Evaluation of Septin9 in Patients With Hereditary Colon Cancer Syndromes
I-Scan For Colon Polyp Detection In HNPCC
Psychosocial Aspects of Genetic Testing for Hereditary Nonpolyposis Colon Cancer
Molecular Screening for Lynch Syndrome in Southern Denmark